Navigation Links
Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases
Date:6/24/2008

ct of further development and commercialization activities relating to our product candidates. You are urged to consider statements that include the words "ongoing," "may," "will," "would," "could," "should," "believes," "estimates," "projects," "potential," "expects," "suggests," "plans," "anticipates," "intends," "continues," "forecast," "designed," "goal," or the negative of those words or other comparable words to be uncertain and forward-looking. These factors and others are more fully discussed in our periodic reports and other filings with the SEC.

Any forward-looking statements are made pursuant to Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and, as such, speak only as of the date made. Micromet, Inc. undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Micromet, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Micromet Announces Changes in Management Team
2. Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future
3. Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research
4. Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies
5. Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma
6. Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study
7. Micromet Enrolls First Patient in a Phase 1 Clinical Trial with MT110, the First BiTE Antibody for Treatment of Solid Tumors
8. Micromet to Present Clinical Update for BiTE Antibody MT103/MEDI-538 at the International Conference on Malignant Lymphomas
9. Micromets BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkins Lymphoma
10. Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia
11. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... N.Y. , May 27, 2015  VirtualScopics, ... of clinical trial imaging solutions, announced today, ahead ... Medicine (ISMRM) Annual Meeting in Toronto ... operational investments in Magnetic Resonance Elastography (MRE).  VirtualScopics, ... supporting pharmaceutical companies integrating MRE into their global, ...
(Date:5/27/2015)... and NEW YORK , May ... - Over 70% Indonesian men (80 million) ... die annually due to smoking-related conditions; of these, 6% ... million vehicles in Jakarta do ... Indonesia is the fourth most populous country ...
(Date:5/27/2015)... EAST RUTHERFORD, N.J. , May 27, 2015  Cambrex ... Gregory Sargen , Executive Vice President and Chief Financial Officer, ... June 3, 2015 at 8:00 a.m. EDT in ... webcast and slide presentation can be accessed from the Cambrex ... "Webcasts & Presentations", and a replay will be available for ...
Breaking Medicine Technology:VirtualScopics, Inc. Makes Investments In Magnetic Resonance Elastography (MRE) 2VirtualScopics, Inc. Makes Investments In Magnetic Resonance Elastography (MRE) 3VirtualScopics, Inc. Makes Investments In Magnetic Resonance Elastography (MRE) 4Indonesia Respiratory Devices Market is Expected to Grow at a CAGR of 9% - Boosting Growth for Respiratory Disposables 2Indonesia Respiratory Devices Market is Expected to Grow at a CAGR of 9% - Boosting Growth for Respiratory Disposables 3Indonesia Respiratory Devices Market is Expected to Grow at a CAGR of 9% - Boosting Growth for Respiratory Disposables 4
... N.J., Oct. 27 Laureate Pharma, Inc., ... announced today that they have entered into ... AV-203, AVEO Pharmaceutical,s (Cambridge, MA) novel monoclonal ... include process development, protein production, purification and ...
... Samplify Systems, Inc., a leading ... solutions for the medical imaging market, today introduces ... on Samplify,s AutoFocus™ beamforming technology, the SMK9130 is ... end, from probe connector to PCIe connector.  The ...
Cached Medicine Technology:Laureate Pharma Announces New Development and Manufacturing Agreement to Produce AVEO Pharmaceuticals' Antibody Therapeutic 2Samplify's New Medical Ultrasound Development Kit Accelerates Equipment Time to Market By Up to 12 Months 2Samplify's New Medical Ultrasound Development Kit Accelerates Equipment Time to Market By Up to 12 Months 3
(Date:5/27/2015)... This is a professional and ... Omega-3 industry. The report provides a basic overview ... industry chain structure. The Omega-3 market analysis is ... competitive landscape analysis, and key regions development status. ... Company, Seadragon Marine Oils, Norwegian Fish Oil, Croda ...
(Date:5/27/2015)... May 27, 2015 SonarMD, ... SonarMD Platform, a first-of-its kind, cloud-based algorithmic ... patients with chronic gastrointestinal disease. , Developed ... the application allows physicians to monitor their ... ongoing use of electronic health assessment surveys. ...
(Date:5/27/2015)... 27, 2015 “Heroin has never been more ... overdoses are coming from,” says Harford County Sheriff Jeff Gahler, ... 8th. In the surging heroin related incidents in Baltimore, police ... education to prevent heroin addiction and subsequent abuse before it ... Drug Rehab Baltimore is a drug and alcohol rehab facility ...
(Date:5/27/2015)... 2015 For a limited time, San ... offering discounts on facial fillers. Skin loses more than 2 ... 18. This lost collagen can lead to thinning or sagging ... lines. Facial fillers are an excellent way to plump skin ... fillers to create a softer and more youthful appearance, without ...
(Date:5/27/2015)... 2015 A television program using health ... and Roswell Park Cancer Institute winning a ... story, Cancer Can’t Win , highlights the amazing ... Institute. The production team followed five people who were ... they received treatment from doctors and medical experts at ...
Breaking Medicine News(10 mins):Health News:Omega-3 Market: Global 2015 Analysis & 2020 Forecasts on Market Size 2Health News:SonarMD™, LLC, Launches Game-Changing, IBD Population Health Management Platform 2Health News:The Price of Heroin in Baltimore Drops, Surging Use and Causing Rife Overdose Deaths 2Health News:The Price of Heroin in Baltimore Drops, Surging Use and Causing Rife Overdose Deaths 3Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Discounts on Facial Fillers 2Health News:MediaSource Wins New York Emmy® Award as Premier Health Care Storytellers 2Health News:MediaSource Wins New York Emmy® Award as Premier Health Care Storytellers 3
... , , , , ... has agreed to repay more than $500 million in benefits that ... agreement is part of a class action settlement preliminarily approved by ... whose benefits were suspended or denied between 2000 and 2006 will ...
... , WEST PALM BEACH, Fla., Aug. 11 ... he a ring aids and hearing care announced ... designed exclusively for AARP members. The program is scheduled to be made available ... be extended to AARP members in all 50 states and the U.S. territories. ...
... , , , LIONVILLE, ... ) today announced that William Federici, Chief Financial Officer, and Michael Anderson, ... Ninth Annual CJS Securities "New Ideas" Summer Conference on Tuesday, August 18, ... there will be no formal presentation or a webcast, Mr. Federici and ...
... , , ... (RMS), a leading provider for revenue cycle management solutions ... full accreditation with the Financial Services Accreditation Program (FSAP) ... Network Accreditation Commission (EHNAC). EHNAC FSAP-EHN accreditation demonstrates that ...
... , , Survey seeks ... , , CHICAGO, Aug. 11 Participate in ... to/publicsurvey and become eligible to win a $150 Amazon.com ... ADA.org. , , ADA.org provides news and information on hundreds ...
... , , PALO ALTO, Calif., Aug. ... financial results for the second quarter ended June 30, 2009. , ... compared to $15.5 million for the quarter ended June 30, 2008. Revenues ... Pharma Limited that was received in July 2008 and recognized as revenue ...
Cached Medicine News:Health News:Government Stops Unlawful Social Security Suspensions; Agrees to Repay More Than Half a Billion in Back Benefits 2Health News:HearUSA Makes Hearing Aids and Care Available to AARP Members 2Health News:HearUSA Makes Hearing Aids and Care Available to AARP Members 3Health News:HearUSA Makes Hearing Aids and Care Available to AARP Members 4Health News:Revenue Management Solutions, LLC Receives EHNAC Financial Services Accreditation 2Health News:Revenue Management Solutions, LLC Receives EHNAC Financial Services Accreditation 3Health News:American Dental Association Web Survey Offers Chance at $150 Gift Certificate 2Health News:Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 2Health News:Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 3Health News:Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 4Health News:Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 5Health News:Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 6Health News:Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 7Health News:Jazz Pharmaceuticals Announces Second Quarter 2009 Financial Results 8
...
Lacrimal Cannula, Curved - Open End, 21gSize: 21g x 1-1/2"....
PremierEdge™ Implant Knives....
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Medicine Products: